Amazfit Unveils the Cheetah 2 Ultra: The Performance Trail Running Watch Built to Master the Toughest Mountain Trails
13.5.2026 13:00:00 CEST | Business Wire | Press Release
Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the Cheetah 2 Ultra. Building on the momentum of the recently launched Cheetah 2 Pro—designed for road marathoners—the Ultra is a specialized instrument for trail runners who measure success in elevation, unpredictable terrain, and hours spent on the move.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513230718/en/
Built for ultra distances and mountain racing, the Cheetah 2 Ultra combines long battery life, precision navigation, and advanced training insights to carry more distance and control more load.
Amazfit’s Cheetah 2 Ultra is built for runners who prepare for ultra distances and mountain races, boasting 33-hour trail running optimized GPS battery life, full-color contour maps, Grade 5 titanium construction, and advanced training and recovery insights. Amazfit designed the Cheetah 2 Ultra to support the preparation required for long-course mountain racing from start to finish.
Engineered for Distance, Structured for Load
In ultra-running, distance is sustained through endurance, but load must be carried through structure. The Cheetah 2 Ultra pairs a Grade 5 titanium bezel, frame, and back cover with scratch-resistant sapphire glass to deliver exceptional structural integrity and strength without adding unnecessary weight. Built to withstand the rigors of technical mountain trails while remaining light on the wrist, the watch features a vibrant 1.5-inch AMOLED display with up to 3,000-nit peak brightness for clear readability from early alpine starts to late mountain finishes. A built-in dual-mode flashlight, with adjustable white, red, SOS, and Boost modes up to 300 lux, adds confidence during early morning and late evening efforts in the mountains.
Trail-Ready Battery Life That Matches the Distance
Built to support long stretches of training and racing, the Cheetah 2 Ultra offers up to 33 hours of battery life in Trail Running Mode, with the always-on display, heart rate monitoring, dual-frequency GPS, all-satellite positioning, and map navigation enabled. Off the trails, users can expect up to 30 days of typical battery life, helping the Cheetah 2 Ultra keep pace with both training cycles and daily life.
Navigate with Confidence Across Any Terrain
The Cheetah 2 Ultra delivers precision navigation built for the complexity of mountain racing.
- Dual-frequency six-satellite positioning: A circularly polarized GPS antenna ensures accurate, dependable route tracking through dense forests, steep canyons, and technical terrain.
- Alpine-Ready Clarity: A vibrant 1.5-inch AMOLED display protected by scratch-resistant sapphire glass features 3,000-nit peak brightness, making data easily readable under the intense glare of high-altitude sun.
- Full-Color Navigation: Topographic and contour maps deliver responsive navigation with rendering speeds 2.5 times faster and refresh speeds 12 times faster than before. Runners can create point-to-point routes, search nearby points of interest, and automatically reroute without needing a phone or network, so navigation stays reliable when focus and terrain demand the most. The upgraded Trail Running Mode includes a new elevation overview that color-codes slope difficulty across the entire route, giving runners a clear, at-a-glance view of what’s ahead and how to manage it. Trail Running Mode also applies load factor calculations for gradient, terrain resistance, and vertical gain, so exercise data reflects the true intensity of mountain effort.
Train Hybrid. Prepare Better.
Hybrid Training in the Zepp App organizes preparation across endurance, strength, and recovery, with Weekly Structure showing how training load is distributed so athletes can build volume without the fatigue that derails long training blocks. BioCharge™ energy monitoring translates overnight recovery into a daily readiness signal, while VO₂ max, fatigue level, training status, HRV, sleep, and training load insights help runners understand when to push forward and when to recover. Focus turns those signals into a clear training recommendation, helping each day support long-term progress.
With Cheetah 2 Ultra capturing performance in the moment, the system extends from preparation into execution, connecting how runners plan, perform, recover, and adapt over time.
Metrics That Define Progress Over Distance
The Cheetah 2 Ultra translates training data into meaningful guidance for mountain runners. Advanced running metrics, including lactate threshold, running power, pacing analysis, gait tracking, and finish time predictions, give runners a clearer understanding of how they move and how they can improve. Ground contact time and posture tracking add biomechanical depth to help runners train with greater intention across demanding terrain.
For those seeking deeper control, the watch integrates with advanced third-party platforms including TrainingPeaks, Runna, and Intervals.icu, while syncing activities with Strava. With 64GB of onboard storage, the Cheetah 2 Ultra also supports over 100 hours of podcasts and additional mapping.
"The Cheetah 2 Ultra is built for trail runners facing prolonged exposure in unpredictable terrain," said Wayne Huang, CEO of Zepp Health. "By focusing on a 'Structured for Load' design, we’ve refined strength through architecture rather than bulk, creating a tool that supports the runner from the first mile of preparation to the final meter of the race."
Pricing and Availability
The Cheetah 2 Ultra will be available for purchase starting May 13, 2026, for $599.99 on Amazfit.com.
About Amazfit
Amazfit, a global smart wearable and fitness leader, is part of Zepp Health (NYSE: ZEPP), a health technology company with its principal office based in Gorinchem, the Netherlands. Zepp Health operates as a distributed organization, with team members and offices across the Americas, Europe, Asia, and other global markets.
Amazfit builds smart wearables designed around movement—training with intention, recovery with balance, and evolution over time. Built for the way people train today, Amazfit blends endurance, strength, and recovery into a single, coherent rhythm to support sustainable progress over time.
Behind Amazfit is Zepp, which builds the intelligence that supports its training experience. For more information, visit www.amazfit.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260513230718/en/
Contacts
Media Contacts
Max Borges Agency for Amazfit
amazfit@maxborgesagency.com
Mary Thompson Woodbury
Head of PR, Amazfit North America
Mary.woodbury@zepp.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press Release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press Release
HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612936893/en/ HUI (HUI:VSE) merges traditional and crypto finance: commences continuous trading in Vienna with leading market maker and announces impending token listing on major global exchange Emmanuelle Deba
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press Release
India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of its farming population. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202606151544
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press Release
Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom